Thx. I agree . IMHO MITIGATE is a very important trial …. Especially the CAD portion It can confirm the R-IT trend lines without mineral oil being used as the placebo and expand the addressable secondary prevention CAD population ….since there are no LDL and TG level gating factors .
News 
Market Data 
Discover 
